SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)

Clinical trial NCT02419508 · COMPLETED

Trial details

NCT number: NCT02419508
Sponsor: Alcon Research
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Open-Angle Glaucoma Ocular Hypertension

Start date: 2015-08-07
Primary completion: 2018-02-27
Enrollment: 290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.